Amantadine Sulphate Usage in Spine Deformities Corrective Surgeries Patients
The Implications of Amantadine Sulphate Usage in Spine Deformities Corrective Surgeries Patients as Regard Its Effect on the Duration of Wake up Test and Postoperative Opioid Consumption
1 other identifier
interventional
60
1 country
1
Brief Summary
During the surgical procedure of scoliosis correction, large surgery extent and long-lasting strong nociceptive stimulation lead to postoperative pain formation of greater intensity compared with other orthopedic interventions. In these patients, duration of postoperative symptoms is longer, and may lead to persistent pain formation due to developing neuroplastic changes in the central nervous system.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_2
Started Aug 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 3, 2017
CompletedFirst Posted
Study publicly available on registry
June 7, 2017
CompletedStudy Start
First participant enrolled
August 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2019
CompletedJanuary 12, 2021
January 1, 2021
2.4 years
June 3, 2017
January 8, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
postoperative opioid consumption
24 hours postoperative
Study Arms (2)
Group A amantadine sulfate
ACTIVE COMPARATORthe patients will receive amantadine sulfate infusion using the dose 200 mg slowly I.V 3 hours prior to the surgery
Group B ringer lactate
PLACEBO COMPARATORthe patients will receive 500 ml ringer lactate infusion slowly i.v 3 hours prior to surgery.
Interventions
infusion solution for slowly intravenous application 3 hours preoperative
infusion solution for intravenous application 3 hours preoperative
Eligibility Criteria
You may qualify if:
- Being candidate for spine deformity correction surgery(scoliosis and kyphosis )
- Willing to participate in the study
You may not qualify if:
- Patient refusal
- Patients with chronic kidney, lungs,Gastrointestinal tract, liver, or cardiovascular diseases.
- Pregnant or breastfeeding women.
- Allergy to any of the study medications and taking medications that could significantly interact with amantadine (tramadol, atropine,antipsychotic medications)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Assiut governorate
Asyut, Egypt
Related Publications (4)
Snijdelaar DG, Koren G, Katz J. Effects of perioperative oral amantadine on postoperative pain and morphine consumption in patients after radical prostatectomy: results of a preliminary study. Anesthesiology. 2004 Jan;100(1):134-41. doi: 10.1097/00000542-200401000-00022.
PMID: 14695734RESULTEisenberg E, Pud D, Koltun L, Loven D. Effect of early administration of the N-methyl-d-aspartate receptor antagonist amantadine on the development of postmastectomy pain syndrome: a prospective pilot study. J Pain. 2007 Mar;8(3):223-9. doi: 10.1016/j.jpain.2006.08.003. Epub 2006 Sep 22.
PMID: 16996315RESULTGerner P. Postthoracotomy pain management problems. Anesthesiol Clin. 2008 Jun;26(2):355-67, vii. doi: 10.1016/j.anclin.2008.01.007.
PMID: 18456219RESULTSingla N, Rock A, Pavliv L. A multi-center, randomized, double-blind placebo-controlled trial of intravenous-ibuprofen (IV-ibuprofen) for treatment of pain in post-operative orthopedic adult patients. Pain Med. 2010 Aug;11(8):1284-93. doi: 10.1111/j.1526-4637.2010.00896.x. Epub 2010 Jun 30.
PMID: 20609131RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, CARE PROVIDER
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
June 3, 2017
First Posted
June 7, 2017
Study Start
August 1, 2017
Primary Completion
December 30, 2019
Study Completion
December 30, 2019
Last Updated
January 12, 2021
Record last verified: 2021-01